M[icrotubules]{.smallcaps} of eukaryotic cells are involved in a multiplicity of functions requiring polarized, structural elements. During mitosis, they provide the structural framework for the accurate segregation of chromosomes, and during the interphase of most higher eukaryotes, the microtubule cytoskeleton plays both direct and indirect roles in the global organization of cytoplasm, serving as a system of tracks along which intracellular movements occur and upon which cytoplasmic organelles and subcellular compartments are distributed. Microtubules contribute to the generation of cell polarity in a number of ways, both in the general organization of specialized cell types such as neurons ([@B24]; [@B34]), epithelial cells ([@B55]; [@B60]; [@B12]), and oocytes ([@B13]; [@B30]) and in specific behaviors such as cell migration ([@B5]), NK cell--mediated cell killing ([@B28]), and spindle positioning and the determination of cleavage planes in mitosis and meiosis ([@B26]; [@B32]; [@B49]; [@B54]; [@B19]; [@B42]).

Many of the molecular mechanisms controlling cell polarity are thought to be conserved from mammalian cells to simpler eukaryotes such as the yeasts, whose stereotyped patterns of growth reflect an underlying polarity ([@B16]). In the budding yeast *Saccharomyces cerevisiae*, controls on cell polarity are manifest in the processes of budding, bud site selection, and shmooing during mating ([@B52]). Cell polarization is apparent in the fission yeast *Schizosaccharomyces pombe* in the faithful maintenance of a cylindrical cell shape and by growth occurring exclusively at cell ends ([@B39]), as well as in the switch from monopolar to bipolar growth (New-End Take-Off \[NETO\]),^1^ which normally occurs in early G2 and depends on both a critical cell size and successful DNA replication ([@B43]). What roles do microtubules play in these processes? In budding yeast, some cytoplasmic microtubules run from the spindle pole body into the growing bud ([@B6]). However, there is good evidence that microtubules are not involved in the establishment and/or maintenance of cell polarity and budding patterns ([@B25]; [@B27]), although they contribute to nuclear orientation and migration of the nucleus to the bud neck in mitosis and to karyogamy during mating ([@B6]).

Cytoplasmic microtubules in fission yeast show more striking changes in distribution during the cell cycle ([@B23]). At the completion of anaphase, an array of microtubules emanates from the medial division site, and subsequently, interphase microtubules extend along the length of the cell. In contrast to the situation in budding yeast, in fission yeast there is evidence for a role for microtubules in cell polarity, although the nature of this role remains unclear because of variation in morphology and the relatively low penetrance of phenotypes. Cold-sensitive tubulin mutants generate a variety of bent or misshapen cells, including branched cells, albeit at relatively low frequency and after many hours at the nonpermissive temperature ([@B66]; [@B67]). Similar cell shape abnormalities have been observed in the presence of the microtubule inhibitor thiabendazole (TBZ) ([@B70]), as well as in *tea2* mutants, which have abnormally short microtubules ([@B69]). Overexpression of the microtubule-associated protein dis1 also produces abnormally shaped cells ([@B45]), as does mutation or deletion of the microtubule-associated protein mal3 ([@B4]). Furthermore, deletion of the *tea1* ^+^ gene, which is thought to be translocated by microtubules to cell ends, can lead to bent cells as well as branched cells, suggesting that microtubules may mediate delivery of important regulators of cell polarity ([@B38]).

Here we describe an experimental system in which the role of microtubules in controlling cell polarity in fission yeast can be more easily studied. Under specific conditions that depend on both temperature and cell cycle state, the disruption of microtubules results in the establishment of a completely new axis of polarized growth, synchronously producing branched cells from normally cylindrical cells with high efficiency. Using this system, we also demonstrate that cortical filamentous actin as well as other proteins localized to the growing tips of fission yeast depend intimately on microtubules for their normal localization. Interestingly, these proteins eventually (although slowly) return to growing cell tips, apparently independently of the recovery of the microtubule cytoskeleton, suggesting that more than one mechanism may exist to localize components controlling polarized growth in fission yeast.

Materials and Methods {#MaterialsMethods}
=====================

Yeast Strains and Plasmids
--------------------------

A list of strains used in this work is shown in Table [I](#TI){ref-type="table"}. Standard yeast genetic techniques were used throughout ([@B44]). Crosses with *ral3Δ* strains, which are sterile, were performed by first transforming cells with a multicopy plasmid containing the *ral3* ^+^ gene and then mating under selective conditions, later allowing plasmid loss to uncover the *ral3Δ* phenotype. The *nda3-TB101* mutation was originally identified as *ben1-TB101* ([@B73]). To avoid confusion, we shall use the later and more commonly used gene designation *nda3* ([@B66]; [@B67]).

For integrated expression of ral3--green fluorescent protein (GFP), the coding region of ral3/scd2 ([@B18]; [@B9]; for simplicity we shall refer to the gene as *ral3* ^+^) was amplified without a stop codon by PCR, using primers 5′-CCCCTCGAGATTCCAGTCTCTATGTTA-3′ at the 5′ end and 5′-GGGTTGCGGCCGCTGCTGCTGTTGCTGCAAACCTCCGTCTTTCTGC-3′ at the 3′ end, and a template plasmid containing the *ral3* ^+^ gene (gift of M. Yamamoto). The 1.6-kb PCR product was digested with XhoI and NotI and cloned into pMGC ([@B58]), also digested with XhoI and NotI, to create pMral3C. The plasmid pMral3GFP was constructed by subcloning an XhoI/BamHI fragment from pSGA ([@B59]) containing GFPmut2 ([@B14]) into pMral3C digested with SalI and BamHI. pMral3GFP was digested with XhoI and BamHI, and the ral3-- GFP coding sequence was then subcloned into the integrating plasmid REP6X. REP6X is a derivative of REP5 ([@B62]), which drives expression from the *nmt1* promoter ([@B41]) and contains a *sup3-5* suppressor tRNA for selection in *ade6-704* nonsense mutants. Cells were transformed with the resulting construct, pSral3GFPint, and stable Ade+ transformants that had integrated the constructs were selected and screened for expression of the fusion protein. All ral3 constructs rescued the sterility of the *ral3Δ* strain.

Physiological Experiments
-------------------------

Except where indicated, cells were grown in YE5S ([@B44]). For branching experiments with *cdc10-129* mutants and other strains (i.e., as in Figs. [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"} *A*, [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}, *A* and *C*, [8](#F8){ref-type="fig"}, [9](#F9){ref-type="fig"}, [11](#F11){ref-type="fig"}, and [12](#F12){ref-type="fig"}), cells at a density of OD~(595)~ 0.07--0.1 were incubated in flat-bottom flasks in shaking water baths (130--150 rpm) at 36°C for 4 h, at which time 1/100 vol of 10 mg/ml TBZ (made fresh in DMSO) was added to cultures. Cultures were incubated an additional 30 min and then shifted to a 25°C shaking water bath, with time points taken at various intervals. To count the frequency of branched cells, 0.2 ml of culture was added to 0.8 ml formol saline and stored indefinitely until counting. Cell branching was measured under the microscope by counting 200--300 cells per time point for each strain in a given experiment, with phase-contrast optics. Cells with small bumps easily recognizable as the beginning of branches were counted as branched cells, while bent or L-shaped cells (a very small minority; see Fig. [1](#F1){ref-type="fig"}) were not. Under these conditions, reorientation of growth polarity by TBZ was highly reproducible. In preliminary experiments, EMM2 minimal medium ([@B44]) was also used, but it was only 50% as effective at producing branched cells and not as reproducibly. The reasons for this are not yet clear.

Full induction of ral3--GFP expression from the *nmt1* promoter (i.e., in EMM2 minimal medium lacking thiamine) led to protein localization in the nucleus and cytoplasm as well as cell ends, and to small aberrancies in cell morphology ([@B58]). Therefore, for physiological studies ral3--GFP was first induced to full levels in minimal medium, and then cells were transferred to YE5S just before temperature shift-up to shut off any further expression. Within 3--4 h after switching off expression, ral3--GFP was found only at cell ends. Subsequent treatments with TBZ were as described above.

For experiments involving hydroxyurea (HU) addition and removal, HU was added as a 1/100 vol of a 1.1-M stock, made fresh in distilled water, at the start of the experiment. In most cases, a similar amount of HU was added after 3 h as well, to counter adaptation of cells to the drug. For removal of HU, cells were rapidly filtered using a prewarmed filtration apparatus (Millipore Corp., Bedford, MA) and resuspended in their original volume with fresh prewarmed medium, containing TBZ as appropriate to the experiment. Wash-out of HU took 2--4 min from start to finish.

Addition of latrunculin A (LatA) to cells was from a 50 mM stock in DMSO (generously provided by K. Ayscough, University of Dundee, Dundee, UK), and it was added to cells at a final concentration of 100 μM.

Immunofluorescence and Actin Staining
-------------------------------------

For immunofluorescence, cells were harvested by rapid filtration and fixed by washing the filter with methanol at −20°C. Cells were further processed for immunofluorescence as described ([@B38]). Antitubulin staining used the TAT1 monoclonal tissue culture supernatant (gift of Prof. K. Gull, University of Manchester, Manchester, UK; [@B72]) at 1:10 followed by Cy3-labeled Fab2′ sheep anti-- mouse secondary antibody (C-2181; Sigma Chemical Co., St. Louis, MO) at 1:1,000. Anti-tea1 staining was as described ([@B38]), using an antibody raised against the COOH terminus of tea1 at 1:20 and a secondary donkey anti--rabbit whole IgG (N-1034; Amersham Corp., Arlington Heights, IL) at 1:150.

Rhodamine-phalloidin staining of actin was done using a modification of the method of [@B36]. Growing cultures were added directly to 1/3 volume prewarmed 16% EM-grade formaldehyde and fixed for 1 h. Cells were washed three times in one culture vol of 0.1 M Na Pipes, pH 6.8, 1 mM EGTA, 1 mM MgCl~2~ (PEM), extracted for 30 s with PEM/1% Triton X-100, and washed three additional times in PEM. 300 U rhodamine-phalloidin (Molecular Probes, Eugene, OR) was resuspended in 1.5 ml methanol, divided into 15-μl aliquots, evaporated in a speed-vac, and stored at −20°C. For staining, one aliquot was resuspended in 50 μl PEM, and 7 μl of this was added to no more than 1 μl of a pellet of fixed, extracted cells. Cells stained in this manner could be stored for several days at 4°C. For mounting, 0.5 μl of stained cells was spotted onto a glass slide (in some cases precoated with 10 mg/ml polylysine; P-1524, Sigma Chemical Co.), followed by 2.5 μl of a mounting medium of PEM containing 1 mg/ml phenylene diamine as antifade, and in some cases also 50 μg/ ml Calcofluor (F-6259; Sigma Chemical Co.). The presence of glycerol in mounting medium resulted in relatively poor staining of actin, and slides were not coated with polylysine when Calcofluor was used. These procedures gave excellent, reproducible staining of actin, and with careful through-focusing we could see actin cables in essentially all cells, although these generate little contrast and are often out of the plane of focus. Small changes from this procedure, including growing cells in minimal medium, produced poorer results. Because the conditions for good-quality actin staining were incompatible with those for staining of cytoplasmic microtubules, double staining of actin and tubulin was not possible in this work. Similarly, since ral3--GFP visualization is not completely reliable in fixed cells, we could not visualize both actin and ral3--GFP in the same cells.

Changes in actin distribution (Fig. [7](#F7){ref-type="fig"}) were in some cases subtle and therefore scored blind. 100--200 rhodamine-phalloidin--stained cells were counted for each time point, with careful focusing through each cell to identify the presence or absence of cortical actin at cell ends. In Fig. [7](#F7){ref-type="fig"} *C*, actin at cell ends was considered significant if found at levels at least roughly 20% of that found at the branch site, judging under the microscope. ral3--GFP localization (Figs. [10](#F10){ref-type="fig"} and [12](#F12){ref-type="fig"}) was scored in living cells, counting 100 cells per time point.

Microscopy
----------

For fluorescence microscopy, we used a Zeiss Axioplan microscope (Thornwood, NY) equipped with a Zeiss Fluar 100×/1.4 objective, an HBO100 mercury arc lamp, and HiQ fluorescence filters (Chroma Technology, Brattleboro, VT). Differential-interference contrast and fluorescent images were collected with a chilled video-rate CCD camera (model C5985; Hamamatsu, Bridgewater, NJ) controlled by an Apple Power Macintosh 8500 computer (Cupertino, CA) running Hamamatsu software. High-resolution images of actin (Fig. [6](#F6){ref-type="fig"}) were obtained using a cooled slow-scan CCD (Princeton Instruments, Trenton, NJ) controlled by Improvision software, on a Zeiss Axiovert microscope using a 100×/1.4 Planapochromat objective and Chroma Technology filter sets.

For confocal microscopy (Figs. [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, and [9](#F9){ref-type="fig"}), fixed and stained cells were centrifuged onto polylysine-coated coverslips ([@B59]), rinsed to remove nonadherent cells, and mounted in 90% glycerol/20 mM Tris, pH 8.5, containing 1 mg/ml phenylene diamine. Images were collected with a confocal microscope (model TCSM; Leica, Deerfield, IL) and optical sections were projected using Leica software. Maximum projections are shown in Figs. [4](#F4){ref-type="fig"} and [9](#F9){ref-type="fig"}, and a summation projection is shown in Fig. [5](#F5){ref-type="fig"}. All images were subsequently processed using Adobe Photoshop (San Jose, CA).

Results {#Results}
=======

Reorientation of Polarized Growth by TBZ
----------------------------------------

For reasons originally related to determining the potential role of cytoplasmic microtubules in the regulation of NETO, we added the microtubule inhibitor TBZ to cells in a *cdc10-129* block-and-release experiment. *cdc10-129* mutant cells were arrested in a G1 pre-NETO state ([@B47]; [@B43]) by a 4-h temperature shift to 36°C, at which time either TBZ or carrier DMSO alone was added to cultures. After an additional 30 min of incubation at 36°C, cultures were shifted down to the permissive temperature (25°C), and cell growth and morphology followed for an additional 4--5 h, in the continued presence of TBZ (Fig. [1](#F1){ref-type="fig"} *A*). Most control and TBZ-treated cells appeared eventually to undergo NETO after shift-down, although TBZ delayed NETO slightly (data not shown). Strikingly, a considerable proportion of cells to which TBZ had been added also formed branches from their middles (Fig. [1](#F1){ref-type="fig"}, *F* and *H*). Branching occurred with high synchrony, reaching maximal levels of ∼35--40% branched cells within 2 h after shift-down (Fig. [1](#F1){ref-type="fig"} *B*). Branches continued to grow throughout the experiment, and inspection of cell length at different times after shift-down showed that a significant fraction of subsequent extensile cell growth in branched cells was along this new axis of polarized growth (Fig. [1](#F1){ref-type="fig"}, *D*, *F*, and *H*). By contrast, cells to which only DMSO had been added did not form branches to any appreciable extent and merely elongated until cell division (Fig. [1](#F1){ref-type="fig"}, *C*, *E*, and *G*). We also performed the same experiments with strains carrying the *nda3-TB101* allele of β-tubulin, which confers increased resistance to benzamidazole drugs ([@B73]; [@B67]; our unpublished data). Virtually no branches were seen in *cdc10-129 nda3-TB101* double mutants treated either with DMSO or TBZ (Fig. [1](#F1){ref-type="fig"} *B* and additional data not shown), confirming that the effects of TBZ on branching were specific to tubulin.

Cell Cycle Effects
------------------

We next sought to establish more clearly what specific conditions were required to reorient the growth axis. To examine the contribution of cell cycle state to branching, we repeated the same experiment with wild-type cells and with *cdc25-22* mutants, which arrest in late G2, post-NETO ([@B65]; [@B43]). Under the conditions shown in Fig [1](#F1){ref-type="fig"} *A* (we shall refer to this as a "branching experiment"), both wild-type and *cdc25* mutant cells formed branches at only a low frequency (Fig. [2](#F2){ref-type="fig"} *A*). These experiments indicate that the ability to reorient polarized growth in the presence of TBZ is strongly dependent on the cell cycle state.

Temperature-sensitive cell cycle mutants defective in G1/S functions in fission yeast can arrest either in G1 with a 1C DNA content (e.g., *cdc10-129*, *cdc20-M10*, and *cdc22-M45* mutants) or with a 1C-2C DNA content (e.g., *cdc17-K42*, *cdc18-K46*, *cdc19-P1*, and *cdc21-M68* mutants; [@B46]), although all of these mutants fail to execute NETO and thus exhibit only monopolar growth upon cell cycle arrest ([@B43]). To investigate whether the ability to branch in TBZ was a specific consequence of the *cdc10-129* mutation, a G1 state, or a pre-NETO state, we repeated branching experiments with these mutants. As shown in Fig. [2](#F2){ref-type="fig"} *B*, both mutants that do not enter S-phase (*cdc10* and *cdc20*) and mutants that initiate DNA replication (*cdc18* and *cdc21*) formed branches at frequencies between 20 and 35%. Variation in branching frequency may reflect different extents of recovery from the cell cycle block. Similar results were obtained with *cdc17*, *cdc19*, and *cdc22* mutants (not shown). This demonstrates that the ability to reorient polarized growth is not specific to *cdc10* mutants or to a G1 or 1C state but rather is correlated with being in a pre-NETO state.

Cells carrying the *orb2-34* mutation, a viable allele of the essential PAK kinase shk1/pak1 ([@B35]; [@B48]; [@B68]), exhibit only monopolar growth throughout their life cycle ([@B61]; [@B69]). Interestingly, in branching experiments *orb2-34 cdc10-129* double mutants formed branches at only very low levels (Fig. [2](#F2){ref-type="fig"} *C*), suggesting that molecules involved in regulating the transition to bipolar growth may also play important roles in reorienting polarized growth (see Discussion). We also tested branching in cells deleted for the *ral3/scd2* ^+^ gene, which leads to a partial defect in polarized growth and a sterile phenotype ([@B18]; [@B9]). *cdc10-129 ral3Δ* double mutants were able to branch, albeit at lower frequencies than normal (Fig. [2](#F2){ref-type="fig"} *C*). Mutants with a more pronounced loss of polarity (e.g., *ras1Δ*, *ral1Δ/scd1Δ*, and *orb* mutants; [@B18]; [@B9]; [@B61]; [@B69]) could not be tested easily in this assay because of their round phenotype (data not shown).

Mutation of the *tea1* ^+^ gene or the *pom1* ^+^ gene can lead to bent or T-shaped cells at 36°C, as well as defects in bipolar growth, with varying penetrance ([@B69]; [@B38]; [@B3]). Both *cdc10-129 tea1Δ* and *cdc10-129 pom1Δ* double mutants formed branches to the same extent as *cdc10* single mutants in branching experiments (Fig. [2](#F2){ref-type="fig"} *C*), indicating that neither of these gene products is required for efficient branching in TBZ. Moreover, the increase in branched double-mutant cells over time, relative to their initial release from the cell cycle block (i.e., after several hours at 36°C, which uncovers the mutant phenotype), implies that microtubules still make some contribution to maintaining normal cell polarity when tea1 or pom1 function is absent.

Temperature Effects
-------------------

Because our experiments using cell cycle mutants involved temperature shifts, which could affect the cytoskeleton, or cell physiology in general, we investigated the possible contribution of temperature in the reorientation of polarized growth. Several experiments indicated that in addition to cell cycle state, elevated temperature is critical for branch formation. As shown in Fig. [3](#F3){ref-type="fig"} *A*, if the addition of TBZ to *cdc10-129* cells blocked at 36°C was delayed until the time of shift-down to 25°C, cells failed to form branches. Similarly, if TBZ was added after 4 h at 36°C, and cells were then chilled in an ice slurry for the next 30 min before being returned to 25°C, branches did not form (data not shown). In another approach, we used HU to block cells at G1/S in a temperature-independent fashion. Wild-type cultures grown at 25°C were supplemented with HU and shifted to 36°C for 3.5 h, at which time TBZ was added, and after 30 min cells were washed into HU-free medium containing TBZ, at 25°C. Under these conditions, we routinely observed reorientation of polarized growth in 15-- 20% of cells, about half as much as in *cdc10-129* cells (Fig. [3](#F3){ref-type="fig"} *B*). However, if the HU block was carried out at 25 or 32°C, relatively little branching was seen (1--5%; Fig. [3](#F3){ref-type="fig"}, *B* and *C*).

These experiments strongly suggest that elevated temperature is important for efficient branching, but because cells grow more quickly at high temperature, it was possible that the role of temperature might simply be to produce longer pre-NETO cells, which, for reasons yet unknown, might be more likely to branch. We therefore repeated the experiment of blocking cells with HU at 36°C, but shifted cells down to 25°C 15 min before addition of TBZ, washing out HU 30 min after addition of TBZ. Under these conditions, cell length at the time of release from HU was essentially unchanged (by forward scattering data; not shown), but the frequency of branched cells decreased significantly, as shown in Fig. [3](#F3){ref-type="fig"} *C*. We also repeated the HU experiments at 25°C using cells containing three copies of the wild-type *wee1* ^+^ gene ([@B57]). This increased gene dosage results in increased cell length at birth, and as a consequence, at the time of release from HU, *wee1-3x* cells blocked at 25°C were as long or longer than wild-type cells blocked at 36°C (data not shown). However, *wee1-3x* cells did not branch more than control wild-type cells (Fig. [3](#F3){ref-type="fig"} *C*). These results indicate that efficient branching requires pre-NETO cells at 36°C, in which the normal interphase microtubule array has been disrupted. To investigate the structural basis for this branching, we next analyzed the localization of cytoskeletal elements that might be involved in the reorientation of cell growth polarity.

Microtubule Redistribution during Branching
-------------------------------------------

We examined the distribution of microtubules in *cdc10-129* branching experiments by indirect immunofluorescence (Fig. [4](#F4){ref-type="fig"}). In DMSO-treated cells, microtubules appeared normal and generally extended all the way to cell ends (Fig. [4](#F4){ref-type="fig"}, *A--F*). By contrast, in cells treated with TBZ, most microtubules disappeared ([@B1]), leaving short microtubules or microtubule stubs in the vicinity of the nucleus ([@B38]) that remained there throughout the course of experiments (Fig. [4](#F4){ref-type="fig"}, *A′--F′*). In most cells, these short microtubules eventually became a more prominent bundle (judging by an increase in fluorescence intensity), usually associated with and sometimes wrapped around the outer nuclear surface. These bundles are not aberrant intranuclear spindles, as the appearance of bundles precedes the timing of mitosis in control cells, and bundles often leave the vicinity of the nucleus and extend into the cytoplasm (Fig [4](#F4){ref-type="fig"} *F′*).

We also observed microtubules in *cdc10-129 nda3-TB101* mutants under the same conditions. In DMSO, microtubules in *cdc10 nda3* double mutants were indistinguishable from those in *cdc10* single mutants. However, in contrast to *cdc10* mutants, the normal microtubule distribution was only subtly affected by TBZ in *cdc10 nda3* mutants. Double mutants showed somewhat higher soluble tubulin staining (Fig. [5](#F5){ref-type="fig"}, *C* and *D*), although the differences were not as pronounced as in *nda3* ^+^ cells (Fig. [5](#F5){ref-type="fig"}, *A* and *B*), and in a few cases, microtubules no longer reached the very ends of cells (Fig. [5](#F5){ref-type="fig"} *D*, *arrows*). These mild but detectable effects of (100 μg/ml) TBZ on microtubules in the *cdc10-129 nda3-TB101* mutants were similar to those seen with 60 μg/ml TBZ in *cdc10-129* single mutants, a concentration at which little or no branching occurs (data not shown).

The observations of microtubules in the TBZ-treated *cdc10-129* mutants (Figs. [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}) indicate that in TBZ-treated cells, a local concentration of microtubules remains in the cell middle, in a region where prospective branches may subsequently form. In addition, we note that when branches have extended and/or cell length is increased, microtubule ends are typically far away from sites of active growth. (We return to these issues in the Discussion.) It should also be noted that similar distributions of microtubules were seen in wild-type cells upon TBZ treatment, although these do not form branches (data not shown).

Multiple Modes of Actin Organization in the Absence of Microtubules
-------------------------------------------------------------------

In fission yeast, actin is highly enriched at sites of polarized growth ([@B37]). We used a modified method of rhodamine-phalloidin staining ([@B36]) to analyze changes in the F-actin cytoskeleton concomitant to the reorientation of polarized growth (see Materials and Methods). As described previously, in G1-arrested *cdc10-129* cells, which are blocked before NETO, actin was strongly polarized to a single growing end; this is the "old" end preexisting in the mother cell, not the "new" end created by the most recent cell division, which remains dormant until NETO ([@B36]; [@B43]). Actin dots were closely apposed to the cell surface, and in many cases actin cables were seen directed into the end (Fig. [6](#F6){ref-type="fig"}, *A--D*). By contrast, after 30 min in TBZ (i.e., at time of shift-down), actin organization was considerably altered. Actin dots were either randomized throughout cells or, if still near cell ends, no longer tightly associated with the cell cortex (Fig. [6](#F6){ref-type="fig"}, *E--H*). Actin cables could still be observed but no longer pointed strongly to cell ends (not shown). 1--1.5 h after shift-down, we observed small patches of actin dots in cell middles (Fig. [6](#F6){ref-type="fig"}, *I--L*), in approximately the same fraction of cells as would later form branches (29/100 cells). By 2 h after shift-down, a recovery of actin to the extreme cell cortex became obvious, with an increase of actin in the ends of branches and also at either or both of the preexisting cell ends in both branched and unbranched cells (Fig. [6](#F6){ref-type="fig"}, *M--P*; see also Fig. [8](#F8){ref-type="fig"}). We note that at these times, residual microtubules remain far away from cell ends (see Fig. [4](#F4){ref-type="fig"} *E′*). After 3 h, actin in branched cells appeared to be increased at cell ends as well as branches, and in many cases actin cables were highly pronounced, perhaps indicating an involvement in actin redistribution. At this time we could also see the beginnings of actin ring formation in DMSO-treated controls cells (not shown). By 4 h after shift-down, many cells in TBZ also had begun septation (see [@B10]), often creating aberrant actin rings reflecting their branched morphology (Fig. [6](#F6){ref-type="fig"}, *U--X*).

The dispersal of cortical actin soon after TBZ addition was striking and therefore investigated further in wild-type, *cdc10-129*, and *cdc25-22* strains as well as *cdc10-129 nda3-TB101* double mutants, scoring nonbranched cells together with branched cells. In all *nda3* ^+^ strains, we observed a disruption of global actin organization, in most cases within 30 min after TBZ addition (Fig. [7](#F7){ref-type="fig"} *A*), while in the *cdc10 nda3* double mutant, only a mild loss in actin organization was apparent, which is consistent with the effects on microtubule distribution described above. (In the experiment shown in Fig. [7](#F7){ref-type="fig"} *A*, wild-type cells seemed to disorganize more slowly, but this was not always reproduced; for example see Fig. [7](#F7){ref-type="fig"} *B*.) Recovery of actin to the cortex in the presence of TBZ was also seen in all strains, although apparently more slowly in *cdc10* mutants, and at times when actin patches at cell middles could be seen in *cdc10* mutants (Fig. [6](#F6){ref-type="fig"}, *I--L*), the bulk of cortical actin remained disorganized (Fig. [7](#F7){ref-type="fig"} *A*). We also examined whether the disruption of actin by thiabendazole was specific to the temperature shifts used in our experiments, using exponentially growing wild-type cells and *cdc10-129* mutants. Under all conditions tested, actin became deranged within ∼30 min of TBZ addition, independent of temperature and cell cycle state (Fig. [7](#F7){ref-type="fig"} *B*).

While quantitating the recovery of actin to the cortex, we noticed that most cells in early stages of branching contained appreciable amounts of actin only at the "branch end," or at the branch end and one additional end, while at later times branched cells could accumulate actin at all three ends (Fig. [7](#F7){ref-type="fig"} *C*; see also Fig. [6](#F6){ref-type="fig"}, *M--V*). To determine whether actin normally found at the old ends of cells before NETO and TBZ addition was returning faithfully to old ends during recovery to the cell cortex, we costained rhodamine-phalloidin--stained *cdc10-129* cells with Calcofluor. Birth scars created by septum formation stain poorly with Calcofluor, and because new ends initiate growth later than old ends, the new end of a cell can be identified as the end closest to a birth scar ([@B63]; [@B43]). Interestingly, in cells containing actin at the branch and at one additional end, this was found to be either the old end or new end in roughly equal measure (28/52 cells vs 24/52 cells, respectively; Fig. [8](#F8){ref-type="fig"}, *A--D*), suggesting that after derangement of actin and other cortical components by TBZ (see below), the cues specifying preference for growth at old vs new ends are effectively randomized. This view was also supported by the patterns of actin and Calcofluor staining in cells that did not branch. Among cells with actin at a single end, this was very often the new end (35/100 cells; Fig. [8](#F8){ref-type="fig"}, *E--H*), whereas in DMSO-treated control cells, we never observed actin only at the new end (0/100 cells).

Disruption and Relocalization of Other Proteins Involved in Polarized Growth
----------------------------------------------------------------------------

The nature of the dispersal and return of actin in the presence of TBZ led us to examine two additional proteins that have similar localizations and are also involved in the control of polarized growth. Tea1 is localized to the ends of cells whether they are growing or not, and depolymerization of microtubules with TBZ has been shown to disrupt this localization ([@B38]). Using *cdc10-129* cells in branching experiments, we obtained similar results before and up to ∼1.5 h after TBZ addition (Fig. [9](#F9){ref-type="fig"}, *A* and *B*). However, at later times we observed a significant recovery of tea1 to cell ends, in both branched and unbranched cells, without any significant regrowth of microtubules (Fig. [9](#F9){ref-type="fig"}, *C* and *D*). The extent of recovery varied and, as shown in Fig. [9](#F9){ref-type="fig"}, was incomplete as judged by cytoplasmic tea1 staining. Nevertheless, these results indicate that tea1, like actin, can eventually return to cell ends in the absence of microtubules.

We also examined the effect of TBZ on the localization of a fusion protein between GFP and ral3 ([@B18]; [@B9]). Ral3 interacts with scd1/ral1 and cdc42sp ([@B9]), and as a homologue of the budding yeast polarity protein Bem1p, which is present at bud tips ([@B11]; [@B52]), ral3 might be expected to be localized to cell ends. When expressed at moderate levels (see Materials and Methods), ral3--GFP was found exclusively in actively growing cortical regions, as shown in a *cdc25* block-and- release experiment (Fig. [10](#F10){ref-type="fig"}). In *cdc25* mutants blocked post-NETO in late G2, ral3--GFP was located at both ends of cells (Fig. [10](#F10){ref-type="fig"}, *two ends*), while after release from the cell cycle block, when growth is redirected to the middle of the cell in preparation for septation, ral3--GFP redistributed to form a ribbon in the cell middle during early mitosis, which later narrowed during cytokinesis (Fig. [10](#F10){ref-type="fig"}, *middle* and *ring*). Upon completion of septation, ral3--GFP returned to the previously existing old ends, where extensile growth initially occurs (Fig. [10](#F10){ref-type="fig"}, *ring & ends* and *new ends*).

In a branching experiment, ral3--GFP localization in *cdc10* cells was quickly altered by addition of TBZ, leaving the growing old end and acquiring a weaker or random distribution in the cell cortex (Fig. [11](#F11){ref-type="fig"}, *A--C*). At later times, ral3--GFP recovered to the cortex, forming a small patch near the cell middle in some cells. This was seen in a similar number of cells as would later form branches and appeared to mark the future branch site, after which ral3-- GFP was localized to the end of the branch. In cells that did not branch, ral3--GFP returned to the original cell ends (Figs. [11](#F11){ref-type="fig"}, *D--H*, and 12 *A*), and a similar disruption and recovery were observed in wild-type cells as well, with some cells localizing ral3--GFP to the cell middle (data not shown). By contrast, in *cdc10 nda3* double mutants, a relatively small perturbation in ral3--GFP localization was seen, without a significant increase in cells bearing ral3-- GFP at the cell middle (Fig. [12](#F12){ref-type="fig"} *B*).

The kinetics of ral3--GFP arrival at this middle cortical site in *cdc10-129* mutants (Fig. [12](#F12){ref-type="fig"} *A*) suggested that localization of ral3--GFP to the cell middle might precede the formation of the actin patch that also appears before branch formation. To test this further, we added the actin inhibitor LatA ([@B2]) to *cdc10* mutants treated with TBZ. Disruption of the F-actin cytoskeleton with LatA completely inhibited both cell growth and branching but did not prevent an accumulation of ral3-- GFP at the cell middle (Fig. [11](#F11){ref-type="fig"}, *I* and *J*; additional data not shown), implying that ral3--GFP recruitment to the cell middle is independent of actin. However, in LatA-treated cells, ral3--GFP middle localization was typically found more as a ribbon than a patch and not as strongly consolidated to a single region, suggesting that actin may nevertheless play a role in concentrating ral3--GFP after its initial redistribution to the cell middle.

Discussion {#Discussion}
==========

We have shown that a new axis of polarized growth is established in fission yeast upon TBZ-induced disruption of cytoplasmic microtubules. This provides a simple system for studying the establishment of cell polarity, one in which the creation of a new growing end can be dissociated from the complexities of cytokinesis and septation. The extent and synchrony of branching seen in our experiments is much greater than has been described previously with cold-sensitive tubulin mutants or microtubule-destabilizing drugs ([@B70]; [@B66]; [@B67]) and depends on the convergence of several conditions. Branching occurs at high frequency only when TBZ is added to cells that have not gone through NETO, the transition from monopolar to bipolar growth, which usually occurs in G2 ([@B43]). This suggests that some of the mechanisms normally used in NETO are also involved in branching, which is consistent with our observation that *orb2-34* mutants, defective in bipolar growth, are also defective in branching. However, other genes involved in bipolar growth, such as *pom1* ^+^, and to a lesser extent *tea1* ^+^ ([@B69]; [@B3]), are not required for branching in TBZ.

In addition, branching is efficient only when TBZ is added to cells at elevated temperature (36°C). Why high temperature is required is not yet clear. This could be a consequence of general changes in cell physiology at constant elevated temperature, although transient "heat-shock" effects of elevated temperature are likely to be minimal after 4 h of incubation. It is also possible that there may be specific temperature-dependent effects of TBZ ([@B6]), although we have not detected obvious differences in fission yeast by immunofluorescence (Sawin, K.E., unpublished data). We suspect there may be specific temperature-sensitive components in the pathways that lead to branching, and such components could be identified in future work. A similar temperature-dependent phenomenon is observed in *tea1* and *tea2* morphological mutants in the absence of TBZ: At 25°C, many cells are bent, but none branched, while at 36°C, up to 15% branched cells can form ([@B69]; [@B38]). It should be noted, however, that the requirement for high temperature does not appear to be absolute since branching is seen, albeit at low frequencies, in cold-sensitive tubulin mutants at 18--20°C ([@B66]).

Dynamics of Actin and Cortical Components
-----------------------------------------

Actin, tea1, and ral3--GFP all adopt aberrant distributions after the depolymerization of microtubules, suggesting a close coupling between microtubules and actin and other cortical components in fission yeast. Functional interactions between microtubules and actin filaments are recognized in many behaviors of higher eukaryotic cells, including neuronal growth cone and fibroblast cell motility ([@B22]; [@B5]; [@B64]; [@B8]) and cytokinesis ([@B17]; [@B53]; [@B71]). Relatively little is known about the molecules or mechanisms mediating these interactions ([@B20]), although some microtubule-associated proteins may also bind to actin (see [@B15]), and more indirect links may also exist (see [@B31]). The system described here offers the possibility of further investigating these issues from a genetic perspective.

We also observed that ral3--GFP, actin, and tea1 could return to cell ends in the absence of recovery of the microtubule cytoskeleton, tea1 more slowly than the others. This presents a paradox, for if localization of these proteins to cell ends normally depends on microtubules, how do they return in the absence of microtubule recovery? We can imagine two explanations. First, there may be sufficient recovery of microtubules, perhaps only transiently, to allow cortical markers such as tea1 and actin to return to cell ends in a microtubule-dependent manner. Since we have no evidence for even a modest recovery of microtubules, we consider this unlikely. We favor a second view, that additional, microtubule-independent mechanisms may exist to restore protein localization to cell ends. The observations that the recovery of tea1 was often incomplete and that in many cells actin was found at new ends but not old ends suggest that recovery may follow physiological principles different from those used before microtubule disruption, and/or that microtubule depolymerization makes two previously different ends the same. One candidate mechanism is that proteins remaining at cell ends in the presence of TBZ act as landmarks to direct the subsequent return of other proteins. For example, although most of tea1 is lost from cell ends during TBZ treatment, a small but clearly visible fraction remains behind in nearly all cells ([@B38] and Fig. [8](#F8){ref-type="fig"}).

The microtubule-dependent localization of tea1 at cell ends has been shown to be highly dynamic ([@B38]), implying both a fast, microtubule-dependent on-rate and a relatively short residence time at cell ends. Our data showing the accumulation of tea1 to near-normal levels at cell ends in the absence of rapid microtubule-based delivery would seem to require that the residence time of tea1 at cell ends must increase during recovery. More generally, we would speculate that changes in turnover of cortical proteins at cell ends may be important for the recovery seen in our experiments. This could involve the activation of a specific program in response to microtubule depolymerization, as a kind of fail-safe mechanism; alternatively, changes in the dynamics of cortical protein complexes could simply be an indirect consequence of microtubule depolymerization, as would occur, for example, if the factors that promote turnover of complexes were themselves delivered by microtubules.

Mechanics of Branch Formation
-----------------------------

Why do only some cells in a population form branches, and what determines the site of actin accumulation at cell middles before branching? Our experiments suggest two possible models (Fig. [13](#F13){ref-type="fig"}): First, by analogy to hypothesized microtubule function in normal cells ([@B38]), residual microtubules left after TBZ treatment could contribute to branch formation by targeting the growth machinery to an incorrect place. Although residual microtubule ends do not seem to point to a specific cortical spot before branching in the way that microtubules point towards ends of untreated cells (see Fig. [4](#F4){ref-type="fig"}), a high local concentration of microtubules or microtubule ends in the middle of some cells could serve as a kind of attractor for components of the growth machinery. These might then diffuse to the nearby cortex and accumulate to an amount sufficient for the self-organization and maintenance of a new growth axis.

A second model emerges from the observation that before branching, ral3--GFP can move to the cell middle, temporally preceding and independent of the appearance of actin patches. This suggests that relocated cortical complexes containing ral3 and other proteins ("ral3 complexes") may provide the initial cue for the recovery of actin and other components of the growth machinery, and cell-to-cell variation in the extent to which ral3 complexes relocate from ends might then determine whether, and where, a cell will branch. This second model requires some qualification. First, our results have been obtained with ral3--GFP rather than endogenous ral3 (although ral3-- GFP rescues a ral3Δ strain; see Materials and Methods). Second, because ral3 itself is not required for branching, it seems more plausible that a protein in the ral3 complex other than ral3 itself may be a critical determinant. In budding yeast, the ral3 homologue Bem1p is thought to play a scaffolding role and interacts with many proteins involved in cell polarity and signal transduction ([@B51]; [@B29]; [@B33]; [@B50]). These include Ste20p, the homologue of shk1/pak1/ orb2, which we have shown to be important for branching. Finally, as even nonbranching wild-type cells show some delocalization of ral3--GFP upon microtubule disruption, we should emphasize that the relocation of a ral3 complex would be interpreted as a cue for branching only when cells are generally capable of branching, i.e., subject to cell cycle and temperature controls.

These two views of the mechanisms underlying branching are not mutually exclusive, as ral3--GFP localization could itself be dependent on residual microtubules left by TBZ treatment. However, tea1, whose localization in wild-type cells depends on microtubules, does not behave like ral3--GFP, and thus a simple model based on microtubule distributions seems unlikely. In addition, it is not yet clear to what extent ral3--GFP localization in TBZ is a direct consequence of microtubule depolymerization or an indirect consequence in response to actin reorganization. In both *cdc10-129* and wild-type cells, ral3--GFP localization to cell ends is altered by LatA-induced actin disruption, but these effects are not as pronounced as those seen in TBZ; tea1 localization is only subtly affected by actin disruption (Sawin, K.E., unpublished data; see also [@B38]). From this it seems likely that several factors contribute to branch site selection and establishment. Further analysis of the localization of ral3 and its associated proteins will help to address these questions, as well as whether a specific role is played by the position of the nucleus, which roughly corresponds to the site of cortical patches and branching (Sawin, K.E., unpublished data).

Implications for Microtubule Function in Cell Polarity
------------------------------------------------------

Why do fission yeast normally grow only at their ends? One idea is that cell form may be dictated by microtubules constantly exploring the three-dimensional space of the cell and aligning along its long axis, thereby defining sites for new growth, presumably through microtubule-dependent transport of determinants or components of cell growth machinery. Evidence for this view comes from a molecular analysis of the tea1 protein, which is required for accurate cell shape and whose localization to cell ends depends on an intact microtubule cytoskeleton ([@B38]). However, because cells deleted for the *tea1* gene often grow close to normal positions of growth ([@B38]) and in many cases disruption of microtubules either by drug or mutation does not radically alter cell shape ([@B66]; [@B67]; our data for wild-type cells), it is likely that there are additional mechanisms that define intracellular space and sites of growth. Opposing a microtubule-centric dynamic view is the view that specific cortical proteins might act as more static landmarks, or "tags," to mark regions of the cell surface, as in current models of bud-site selection in *S. cerevisiae* ([@B52]; [@B56]; [@B39]) and implied here by the return of actin and tea1 to cell ends in the absence of microtubule recovery. Our experiments argue for a compromise between these two extremes, and we suggest that both models may apply. From our observations of cell--cycle dependent branching, we would argue that the relative importance of microtubules for cell polarity may vary in the cell cycle, and that microtubules are needed most during periods of transition of the actin cytoskeleton---that is, during NETO, and perhaps after cytokinesis as well. The reason for this microtubule requirement could be that during transition periods, the overhaul of the actin cytoskeleton may be so extreme that landmarks are damaged, and microtubules are thus needed to deliver components such as tea1, either to help stabilize landmarks or to complement their function. Outside these transitions, proteins normally delivered by microtubules may no longer be as essential as helpers or place-holders, and mechanisms involving landmarks, which might be established at cell ends, for example, during cytokinesis ([@B39]) may be sufficient to maintain a roughly normal cell shape. Working in concert, these two mechanisms would serve to maintain fission yeast morphology throughout the cell cycle.

Relation to Higher Eukaryotes
-----------------------------

As microtubules contribute to many aspects of polarity in eukaryotic cells (see Introduction), it remains to be seen how similar these functions are between fission yeast and higher eukaryotes. However, two parallels may be worth noting. The first relates to the loss and subsequent redistribution of actin, tea1, and ral3--GFP in TBZ. In human intestinal epithelial cells, microtubule disruption has drastic effects on the rate of polarized delivery of newly synthesized apical proteins, by both the direct and indirect pathways ([@B40]; [@B21]). Under such conditions, while some apical proteins nevertheless eventually achieve a polarized distribution, others are less successful and end up in basolateral regions, which can often assume apical characteristics, including the formation of microvilli ([@B40]; [@B21]). We would suggest that in both these cells and in fission yeast, proper polarization depends on combining microtubule-independent targeting with an important kinetic component provided by microtubule-dependent transport, and that changes in kinetics can have long-lasting effects. The second parallel relates to the phenomenon of branching itself. In cultured neurons from embryonic chick dorsal root ganglia, disruption of microtubules leads to a branched morphology in preterminal regions of the neurite, as a result of the ectopic formation of lamellar regions resembling growth cones in both morphology and behavior ([@B7]). This implies that one "role" of a normal microtubule distribution in neurites may be to locally suppress the formation of new growth cones in regions away from the existing growth cone, and by analogy, in fission yeast, a normal microtubule distribution may act to suppress the formation of a new axis of polarized growth in regions away from the ends of cells.

We thank J. Mata and K. Gull for antibodies, Y. Nakaseko, M. Yanagida, and M. Yamamoto for strains and plasmids, K. Ayscough for latrunculin A, A. Stokes and R. Pepperkok for help with CCD imaging, and P. Jordan for help with confocal imaging. We also thank D. Brunner, J. Mata, A. Murray, and G. Warren for critical reading of the manuscript, and members of the cell cycle laboratory, including J. Mata and D. Brunner, for discussions.

This work was supported by the ICRF, the Helen Hay Whitney Foundation, and the Leukemia Society of America. K.E. Sawin initiated this work as a Fellow of the Helen Hay Whitney Foundation and continued as a Special Fellow of the Leukemia Society of America.

Address all correspondence to K.E. Sawin, Imperial Cancer Research Fund, 44 Lincoln\'s Inn Fields, London WC2A 3PX, UK. Tel.: 44-171-269-3276. Fax: 44-171-269-3610. E-mail: <sawin@europa.lif.icnet.uk>

GFP

:   green fluorescent protein

HU
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LatA

:   latrunculin A

NETO

:   New-End Take-Off

TBZ

:   thiabendazole
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Yeast Strains Used in This Study

  Strain      Genotype                                                     Source
  -------- -- --------------------------------------------------------- -- --------
  PN1         *972 h* ^−^                                                      1
  PN7         *cdc25-22 h* ^−^                                             1a
  PN21        *ade6-704 h* ^−^                                                 1
  PN111       *cdc10-129 h* ^+^                                            1b
  PN135       *cdc17-K42 h* ^+^                                            1c
  PN136       *cdc18-K46 h* ^+^                                            1c
  PN137       *cdc19-P1 h* ^+^                                             1c
  PN138       *cdc20-M10 h* ^+^                                            1c
  PN139       *cdc21-M68 h* ^+^                                            1c
  PN140       *cdc22-M45 h* ^+^                                            1c
  PN359       *cdc25-22 ade6-704*                                              1
  PN585       *wee1* ^+^ *(3x) wee1* ^+^ *::LEU2* ^+^ *leu1-32 h* ^−^      1d
  PN1089      *orb2-34 cdc10-129 ade6-M210 leu1-32 h* ^−^                  1e
  PN1191      *cdc10-129 ade6-704 leu1-32 h* ^+^                               1
  PN1652      *ral3Δ::ura4* ^+^ *ura4-D18 ade6-M210 leu1-32 h* ^90^            2
  PN1733      *tea1Δ::ura4* ^+^ *ura4-D18 ade6-M210 h* ^−^                 1f
  JB110       *pom1Δ::ura4* ^+^ *ura4-D18 h* ^−^                               3
  HM318       *nda3-TB101 ura1-61 leu1-32 ade6-M210 h* ^+^                     4
  KS153       *ral3Δ::ura4* ^+^ *ura4-D18 cdc10-129 h* ^90^                1g
  KS189       *tea1Δ::ura4* ^+^ *ura4-D18 cdc10-129 h* ^+^                 1g
  KS179       *pom1Δ::ura4* ^+^ *cdc10-129 h* ^+^                          1g
  KS165       *nda3-TB101 cdc10-129 h* ^+^                                 1g
  KS101       PN21 with integrated *nmt1*::ral3-GFP                        1g
  KS110       PN1191 with integrated *nmt1*::ral3-GFP                      1g
  KS113       PN359 with integrated *nmt1*::ral3-GFP                       1g
  KS217       *nda3-TB101 cdc10-129 leu1-32 ade6-704 h* ^+^                1g
               with integrated *nmt1*::ral3-GFP                            

Sources of strains: (*1*) Nurse laboratory stock, with references: (*a*) [@B65] (*b*) [@B47], (*c*) [@B46], (*d*) [@B57], (*e*) [@B61], (*f*) [@B38], and (*g*) this study; (*2*) M. Yamamoto (University of Tokyo, Japan) ([@B18]); (3) J. Bähler (Imperial Cancer Research Fund) ([@B3]); (*4*) M. Yanagida (University of Kyoto, Japan) ([@B73]).  
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Formation of branched cells in fission yeast *cdc10-129* mutants by treatment with TBZ. (*A*) Experimental design (see Materials and Methods for further details). (*B*) Percentage of branched cells formed after addition of carrier DMSO to *cdc10-129* mutants and TBZ to *cdc10-129* mutants and *cdc10-129 nda3-TB101* double mutants at different times after release from the 36°C cell cycle block. (*C--H*) Differential-interference contrast images of *cdc10-129* cells treated with DMSO (*C*, *E*, and *G*) or TBZ (*D*, *F*, and *H*) at 0 (*C* and *D*), 2 (*E* and *F*), and 4 (*G* and *H*) h after release. The tiny extrusions seen at many cell tips are an artifact of lengthy formaldehyde fixation. Cells in *D* are shorter than those in *C* as a consequence of the 30-min exposure to TBZ. Bar, 20 μm.
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![Branching depends on cell cycle state and coincides with cells not having undergone NETO. (*A*) Percentage of branched cells induced by TBZ in wild-type, G1-arrested *cdc10-129*, and G2-arrested *cdc25-22* cells, at different times after shifting from 36 to 25°C, following the regime shown in Fig. [1](#F1){ref-type="fig"}. (*B*) TBZ-induced branching in other cell cycle mutants defective in G1/S functions, following the same regime. *cdc18-K46* and *cdc21-M68* mutants arrest with an incomplete or defective round of replication, while *cdc10-129* and *cdc20-M10* mutants arrest with a 1C DNA content; all mutants arrest in a pre-NETO state. (*C*) Branching induced by TBZ in different cell polarity mutants, following the same regime as above. Note that *cdc10-129 orb2-34* double mutants show a great reduction in branching, while *cdc10-129 ral3Δ* mutants are less impaired. Note also that *cdc10-129 tea1Δ* and *cdc10-129 pom1Δ* mutants already have 5--6% branched cells at the time of release from the cell cycle block, but this increases to very high levels after release. In these experiments, results from *cdc10-129* single mutants and wild-type cells (not shown) were comparable to those shown in Figs. [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} *A*.](JCB33009.f2){#F2}

![Branching requires elevated temperature. (*A*) Reduction of branching caused by adding TBZ at the time of release of the *cdc10-129* cell cycle block (4.5 h) instead of at the normal time 30 min before release (4 h), following the regime of Fig. [1](#F1){ref-type="fig"}. (*B*) Branching induced by TBZ in wild-type cells in HU block-and-release experiments. Cells were blocked in HU for the total time shown, with TBZ addition 30 min before washing out HU (see text for further details). Extensive branching occurs after the 36°C HU block only. All temperatures produced G1-arrested cells at the time of TBZ addition (not shown). (*C*) Increases in cell length do not account for increased branching at high temperature. Cells were blocked for a total of 4 h in HU, adding TBZ 30 min before release by HU wash-out. Branching is reduced by dropping the temperature from 36°C to 25°C 15 min before TBZ addition. In addition, increased cell length at 25°C in a strain carrying extra copies of the *wee1* ^+^ gene (*wee1-3x*) does not increase the frequency of branching (see text for further details).](JCB33009.f3){#F3}

![Microtubules in *cdc10-129* cells treated with DMSO or TBZ, shown at different times after shifting from 36 to 25°C. (*A--F*) DMSO-treated cells. (*A′--F′*) TBZ-treated cells at 0 (*A* and *A′*), 0.5 (*B* and *B′)*, 1.0 (*C* and *C′*), 1.5 (*D* and *D′*), 2.0 (*E* and *E′*), and 3.5 h (*F* and *F′*) after shift-down. Note that residual microtubules remain in TBZ-treated cells but do not reach cell ends as in DMSO-treated cells; note also bundles of microtubules around the cell nucleus at later times (*E′* and *F′*). Images are maximum projections of series of confocal sections, all taken at the same exposure. Bar, 10 μm.](JCB33009.f4){#F4}

![Microtubules in *cdc10-129* (*A* and *B*) and *cdc10-129 nda3-TB101* (*C* and *D*) cells in a branching experiment like that shown in Fig. [1](#F1){ref-type="fig"}. Cells are shown 30 min after addition of either DMSO (*A* and *C*) or 100 μg/ml TBZ (*B* and *D*). Note that microtubules are significantly less perturbed by TBZ in *cdc10 nda3* double mutants, but in some cases microtubules do not completely reach the cell ends (*D*, *arrows*). Bar, 10 μm.](JCB33009.f5){#F5}

![Rhodamine-phalloidin staining of F-actin during TBZ-induced branching in *cdc10-129* cells. Individual cells after 4 h at the restrictive temperature just before TBZ addition (*A--D*), at the time of temperature shift-down, 30 min after TBZ addition (*E--H*), and 1.0 (*I--L*), 2.0 (*M--P*), 3.0 (*Q--T*), and 4.0 (*U--X*) h after shift-down. Note the close apposition of actin to extreme cortical regions in *A--D*, in contrast to the more random appearance in *E--H*. Note also the appearance of actin patches at the cell middle in *I--L*, and the extensive actin filament networks, which are particularly obvious during branching. Bar, 10 μm.](JCB33009.f6){#F6}

![Time course of actin dispersal and subsequent recovery to cell ends upon TBZ treatment. Rhodamine-phalloidin stained cells. (*A*) Percentage of cells with actin closely apposed to cell ends after TBZ treatment, in wild-type, *cdc10-129*, *cdc10-129 nda3-TB101*, and *cdc25-22* cells, following the regime in Fig. [1](#F1){ref-type="fig"}. Actin is transiently deranged in all *nda3* ^+^ cells but recovers within 2--2.5 h of TBZ addition. *cdc10 nda3* double mutants show only a little actin disorganization and recover quickly; data for *cdc10 nda3* double mutants are from a separate experiment in which actin distribution in *cdc10* single mutants with and without TBZ was as expected. Arrow marks the time of shift to 25°C to release the cell cycle block; dashed line indicates when actin can be found in cortical patches near cell middles in *cdc10-129* cells. (*B*) Actin dispersal after TBZ addition to wild-type and *cdc10-129* cells growing exponentially at 25 and 36°C. Note that effects of TBZ are independent of cell cycle and temperature. (*C*) Movement of cortical actin into cell ends in branching *cdc10-129* cells. Time course based on counting rhodamine-phalloidin staining after shift-down to 25°C. Note that at the onset of branching, most branched cells have appreciable amounts of actin in the branch only. At later times, actin is enriched at the original cell ends as well.](JCB33009.f7){#F7}

![Return of actin to either "old" or "new" ends after dispersal by TBZ, in both branched and unbranched cells. Doubly-stained cells showing both cortical F-actin by rhodamine-phalloidin staining (*A--H*) and new-end growth beyond most recent birth scars, by Calcofluor staining (*A′--H′*). (*A* and *B*) Actin at branch and old end. (*C* and *D*) Actin at branch and new end. (*E* and *F*) Actin at old end in unbranched cells. (*G* and *H*) Actin at new end in unbranched cells. Bar, 10 μm.](JCB33009.f8){#F8}

![tea1 is delocalized by TBZ but returns to cell ends in the absence of microtubule recovery. *cdc10-129* cells, produced by the methods shown in Fig. [1](#F1){ref-type="fig"}, at the time of TBZ addition (i.e., 30 min before shift-down; *A*) and 1 (*B*) and 4 h (*C* and *D*) after shift-down, showing antitubulin staining (*A--D*), anti-tea1 staining (*A′--D′*), and merged image of antitubulin and anti-tea1 staining (*A″--D″*). Note that in some cells in *C* and *D*, tea1 returns to high levels at cell ends without any obvious microtubules, although residual tea1 remains in the cytoplasm. Images are maximum projections of series of confocal optical sections, taken at the same exposure. This may exaggerate to some extent the amount of delocalized tea1 at later times. Bar, 10 μm.](JCB33009.f9){#F9}

![Redistribution of ral3--GFP to the cell middle upon addition of TBZ. (*A--H*) Localization of ral3--GFP in live *cdc10-129* cells in a branching experiment, following the regime shown in Fig. [1](#F1){ref-type="fig"}. Cells are shown before TBZ addition (*A*) and 23 (*B*), 36 (*C*), 86 (*D*), 105 (*E*), 107 (*F*), 153 (*G*), and 216 (*H*) min after TBZ addition. Cells were shifted down to 25°C 30 min after TBZ addition. (*I* and *J*) Localization of ral3--GFP in a parallel experiment in which 100 μM LatA was added to cultures 15 min after TBZ addition. Note that at 63 (*I*) and 85 (*J*) min after TBZ addition, ral3--GFP is found in the cell middle, although it is more weak and diffuse. Some cells appear wider than normal in part because of flattening. Bar, 10 μm.](JCB33009.f11){#F11}

![Quantitation of ral3--GFP localization in a branching experiment, in *cdc10-129* single mutants (*A*) and *cdc10-129 nda3-TB101* double mutants (*B*), following the same regime shown in Fig. [1](#F1){ref-type="fig"}. Cells were shifted to 25°C 30 min after TBZ addition. Note that in the *cdc10 nda3* double mutant, there is only a modest loss of ral3-- GFP from cell ends and no accumulation of middle localization.](JCB33009.f12){#F12}
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Redistribution of ral3--GFP to the cell middle after release from a G2 arrest. *cdc25-22* mutants expressing an integrated ral3--GFP fusion protein were shifted to 36°C for 4 h and then shifted down to 25°C to enter mitosis synchronously. Right panels show different observed distributions of ral3--GFP in live cells after release, and the corresponding left panels show the frequency of different distributions over time. Note that "middle" localization represents an intermediate between the localization of ral3-- GFP at cell ends in G2 and the ring formed at cytokinesis. After cell division, ral3--GFP returns to the "old" ends, which preexisted in the mother cell and which are the sites of initial extensile growth. Background fluorescence is predominantly mitochondrial autofluorescence. Some cells appear wider than normal because of flattening under the microscope. Bar, 10 μm.
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![A model for the reorganization of cellular architecture during branching. In *A*, before TBZ addition, microtubules extend the length of a pre-NETO cell. tea1 is found at both ends, and actin and ral3 are at the growing end. Upon depolymerization of microtubules in *B*, actin leaves the cell cortex, tea1 is mostly delocalized, and a complex containing ral3 is initially delocalized and later concentrated in the cell middle. In *C*, actin is recruited to a site in the cell middle, either through the high local concentration of microtubules in the vicinity of the nucleus or by the ectopic ral3 complex, resulting in the initiation of growth along a new axis in *D*. Growth continues in *E*, with continued recovery of tea1 and actin to cell ends in the absence of microtubules.](JCB33009.f13){#F13}
